Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Investigators report that estradiol works as well as luteinizing hormone–releasing hormone agonists for testosterone suppression and have a much better side-effect profile.

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

Scientists comment on a press release from EDX that gives findings on a new screening test for prostate cancer. Prof Derek Rosario, Consultant Urological Surgeon, Honorary Professor and Clinical ...

According to EDX, the test studies the most comprehensive range of clinically validated prostate-related biomarkers currently ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and ...

Canned tuna distributed by Tri-Union Seafoods has been recalled due to a risk of serious, possibly fatal food poisoning.

ADB announced plans to provide at least $14 billion over 2022-2025 in a comprehensive program of support to ease a worsening food crisis in Asia and the Pacific, and improve long-term food security by ...

Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...

Secondary endpoints included OS, objective response rate (ORR), duration of response (DoR), prostate-specific antigen (PSA) response ... combination with XTANDI was approved by the U.S. Food and Drug ...